Diasome Pharmaceuticals receives $30M funding led by Medicxi to continue clinical development of its novel therapy for the treatment of diabetes

Name: BRASCON 2018
Start: 2018-06-23T00:00:00-04:00
End: 2018-06-24T23:59:59-04:00
Location: Ohio Union